RVMD Research and Charts

RVMD - Revolution Medicines Inc Ordinary Shares (Healthcare: Biotechnology)

Projected Earnings Date: 2025-11-04 (Delayed quote data 2025-10-28)

Last 58.17	Change ⇑ +0.18 (+0.31%)	Volume 1,914,588
	Open 57.86	High 58.66	Low 57.53

8EMA (Daily) 54.17	40EMA (Daily) 47.14	50EMA (Daily) 46.03	STO (Daily) 83.068	MACD Hist (Daily) 0.787
8EMA (Weekly) 49.986	40EMA (Weekly) 42.82	50EMA (Weekly) 42.24	STO (Weekly) 91.955	MACD Hist (Weekly) 2.043


Company Profile
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products include RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.